Today, the FDA approved Lilly's new oral treatment for people with ESR1-mutated #BreastCancer#, which targets two key drivers of ER+ breast cancer. Learn more:
AstraZeneca's breast cancer pill failed to delay disease progression more than the standard treatment in a late-stage trial, results that could dampen optimism around the medicine.
AstraZeneca's breast cancer pill was approved by the FDA, a win for the drugmaker following an earlier vote against the medicine by the agency’s advisory panel
This mother was diagnosed with stage 3 breast cancer while pregnant, leading her to remove one breast.
Her greatest fear wasn’t her own health, but the life of her baby.
She gave birth to her son at 36 weeks and breastfed him.
Motherhood is irreplaceable.